On January 14, Lipocine Inc. (LPCN) stock collapsed in the after-hours to lose 9.49% at 29.36K shares. No news from the company seems to be
Lipocine Inc. (LPCN) shares surged 11.63% in after-hours on Wednesday, July 14, 2021, and closed the trading at $1.44 per share. Earlier in the morning
The American stock markets plummeted again yesterday. The S&P 500 fell 1.31% and the Nasdaq even lost 2.70% and closed at 12,997 points. On balance,
Lipocine Inc. (Nasdaq: LPCN), shares have changed -12.80% in price in a 5-day period, and -10.63% in the past three months. Shares of LPCN are
Last week indices in the United States managed to set fresh records on the price boards. Interestingly, we saw Wall Street indices initially take a
Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market
It is evident with so many people focused on COVID-19 that biotech stocks with coronavirus vaccines and treatments have gained a lot of attention. The
Lipocine Inc. (NASDAQ: LPCN), shares jumped 22.62% in the after-hours after the announcement by the clinical-stage biotech firm focusing on metabolic and endocrine diseases, recently
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.